Showing results (2371-2380 of 2,384) with videos related to

Sort By:
Pageof 239
Journal of Medical Genetics|September 21, 2021
Role of genetics in amyotrophic lateral sclerosis: a large cohort study in Chinese mainland populationYong-Ping Chen, Shi-Hui Yu, Qian-Qian Wei, et al.
Ebiomedicine|January 7, 2024
Cell-free DNA testing for early hepatocellular carcinoma surveillanceLei Chen, Tong Wu, Rong Fan, et al.
Journal of Hematology & Oncology|January 4, 2023
The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosisTong Wu, Rong Fan, Jian Bai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2026
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III TrialWei-Jian Mei, Xiao-Zhong Wang, Xuan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma PatientsBo Zheng, Xiao-Long Liu, Rong Fan, et al.
Nature|February 4, 2026
Atlas-guided discovery of transcription factors for T cell programmingH Kay Chung, Cong Liu, Anamika Battu, et al.
Nature Communications|June 27, 2023
Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockadeJuan Carlos Yam-Puc, Zhaleh Hosseini, Emily C Horner, et al.
Science (New York, N.Y.)|November 6, 2020
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive SpikeMichael Schoof, Bryan Faust, Reuben A Saunders, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformationMichael Schoof, Bryan Faust, Reuben A Saunders, et al.
Pageof 239